HAE(Haemonetics Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-04-02 | FY 截至 2023-04-01 | FY 截至 2024-03-30 | FY 截至 2025-03-29 | FY 截至 2026-03-28 |
|---|---|---|---|---|---|
| 营业收入 | $993.20M | $1.17B | $1.31B | $1.36B | $1.33B |
| 毛利润 | $505.50M | $615.10M | $691.55M | $748.96M | $787.59M |
| 营业利润 | $80.75M | $156.03M | $164.88M | $221.82M | $156.73M |
| 净利润 | $43.38M | $115.40M | $117.56M | $167.68M | $97.31M |
| 经营现金流 | $172.26M | $273.06M | $181.75M | $181.72M | $293.22M |
| 自由现金流 | $75.75M | $81.73M | $143.63M | $142.45M | $260.44M |
| 摊薄每股收益 | $0.84 | $2.24 | $2.29 | $3.31 | $2.05 |